Advertisement
Advertisement
BDSX
Biodesix, Inc. Common Stock
8.53
USDSponsored
-11.31
-57.01%
Nov 06, 15:59 UTC -5
Closed
After-Market
9.00
+0.47
+5.51%
Biodesix, Inc. Common Stock (BDSX) Earnings
BDSX Earnings Reports
Positive Surprise Ratio
BDSX beat 17 of 25 last estimates.
68%
Next Report
Date of Next Report
Feb 24, 2027
Estimate for Q4 26 (Revenue/ EPS)
$32.55M
/-$0.43
Implied change from Q3 26 (Revenue/ EPS)
+35.41%
/-42.67%
Implied change from Q4 25 (Revenue/ EPS)
+29.44%
/-12.24%
Biodesix, Inc. Common Stock earnings per share and revenue
On Nov 05, 2026, BDSX reported earnings of -0.75 USD per share (EPS) for Q3 26, beating the estimate of -0.76 USD, resulting in a 1.77% surprise. Revenue reached 24.04 million, compared to an expected 28.04 million, with a -14.25% difference. The market reacted with a -57.01% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 5 analysts forecast an EPS of -0.43 USD, with revenue projected to reach 32.55 million USD, implying an decrease of -42.67% EPS, and increase of 35.41% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Sonida Senior Living, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.54
Actual
-$0.65
Surprise
-19.11%
Nutex Health Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$5.82
Actual
$5.71
Surprise
-1.93%
Omada Health, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.01
Actual
$0.17
Surprise
+900.00%
CryoPort, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.25
Surprise
-38.97%
Shoulder Innovations, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.34
Surprise
+32.57%
SkinHealth Systems Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$1.30
Actual
-$0.14
Surprise
+89.28%
Natera, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.29
Actual
-$0.39
Surprise
-30.65%
Viatris Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.64
Actual
$0.71
Surprise
+9.31%
Solventum Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.38
Actual
$1.45
Surprise
+5.02%
Concentra Group Holdings Parent, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.44
Actual
$0.52
Surprise
+16.88%
FAQ
What were Biodesix, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Biodesix, Inc. Common Stock reported EPS of -$0.75, beating estimates by 1.77%, and revenue of $24.04M, -14.25% below expectations.
How did the market react to Biodesix, Inc. Common Stock's Q3 2026 earnings?
The stock price moved down -57.01%, changed from $19.84 before the earnings release to $8.53 the day after.
When is Biodesix, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 24, 2027.
What are the forecasts for Biodesix, Inc. Common Stock's next earnings report?
Based on 5
analysts, Biodesix, Inc. Common Stock is expected to report EPS of -$0.43 and revenue of $32.55M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.